Because KRAS mutations can stimulate PI3K activity and were observed in 16% (4/25) of endometrioid tumors, the frequency of the PI3K pathway aberration due to PIK3R1, PIK3CA, PTEN, and KRAS mutations may increase to 60% (15/25) in this histotype. Here, KRAS is linked to endometrioid tumor.